ACUTE LEUKEMIAS XVII
Biology and Treatment Strategies

Munich, Germany - February 24-27, 2019

International Symposium

CORPORATE SUPPORT

The support of ACUTE LEUKEMIAS XV by the following companies is gratefully acknowledged:

 

Gold Circle Corporate Members:

 

Amgen GmbH
SAT III: Monday, Feb 23, 2014
€ 20.000

 

 

Celgene GmbH
SAT IV: Tuesday, Feb 24, 2014
€ 20.000

Gilead Sciences GmbH
MTP II: Monday, Feb 23, 2014 and AGIHO Grant
€ 18.000

Janssen Pharmaceutical Companies
of Johnson & Johnson in EMEA

SAT II: Sunday, Feb 22, 2014
€ 18.000

Pfizer Pharma GmbH
SAT I: Sunday, Feb 22, 2014
€ 18.000

TEVA GmbH
SAT V: Tuesday, Feb 24, 2014
€ 20.000

 

 

Silver Circle Corporate Member:

 

Neovii Biotech GmbH
MTP I: Monday, Feb 23, 2014
€ 10.000

 

Roche Pharma AG (tbc)
MTP II: Monday, Feb 23, 2014 

€ 10.000

 

 

Other Corporate Support:

 

Medac GmbH
Poster Prices
€ 1.000

 

 

German Research Sponsors:

 


Deutsche Forschungsgemeinschaft



Deutsches Krebsforschungszentrum

 


HelmholtzZentrum München